Close Sidebar
Nordic Life Science
Now Reading
Bonnier Ventures leads a USD 1.3 million investment in Pilloxa for European expansion
Search for content, post, videos
Search for content, post, videos

Bonnier Ventures leads a USD 1.3 million investment in Pilloxa for European expansion

December 3, 2019
1492 Views
Bonnier Ventures, the venture arm of the Bonnier group, has taken the lead in the USD 1.3 million investment round in Pilloxa. Pilloxa, founded in 2015, has developed a patient centric adherence platform consisting of smart hardware, tailored smartphone apps, data visualization and analytics. The
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.

Malin Otmani

Related Posts

Liisa Hurme
January 4, 2023

Orion Corporation has signed a long-term license agreement with Amneal Pharmaceuticals to commercialize Amneal’s generic products in Orion territories. Under the terms of the agreement, Orion is granted exclusive licence to commercialize and sell Amneal’s generic products in most parts of EurAlready a subscriber Login You have read all your…

laboratory-technician-protein-separation_genmab
May 3, 2017

Genmab announces that the European Commission (EC) has granted a marketing authorization for DARZALEX (daratumumab) in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therAlready a subscriber Login You have read all your…

GE Healthcare Life Science Cell Gene Therapy Center Shanghai
July 20, 2018

GE Healthcare Life Sciences opens the company's first cell and gene therapy laboratory in Asia, aiming to enable new developments and commercialization of precision medicine in Asia. According to the company, the center, aligned to GE Healthcare’s Fast Trak China offering, marks a milestoneAlready a subscriber Login You have read all your free articles,…